Something for the future? : "Vitality Biopharma... - AMN EASIER

AMN EASIER

1,314 members1,163 posts

Something for the future?

COwithAMN profile image
COwithAMNAdministratorAMN EASIERVolunteer
6 Replies

"Vitality Biopharma Inc filed an international patent application in March of 2017 that describes compounds discovered to be effective in a drug screening model of neural repair. The underlying patent rights are based on work performed by the Myelin Repair Foundation (MRF), a non-profit disease research organization that was dedicated to developing regenerative therapies for multiple sclerosis. Researchers discovered several investigational and FDA-approved drugs that are useful in effecting remyelination, a form of nervous system regeneration. The discoveries included a compound called Cannabidiol (CBD), that is known to have a positive track record of safety in clinical trials and to provide pain relief through modulation of the vanilloid TRPV1 receptor. As a result, Vitality Biopharma has made broad patent claims covering use of CBD and other TRPV1 agonists for myelin repair and for treatment of demyelinating disorders."

Full story at insiderfinancial.com/vitali...

Written by
COwithAMN profile image
COwithAMN
Administrator
To view profiles and participate in discussions please or .
Read more about...
6 Replies
bluejadedwho profile image
bluejadedwho

Cannabinol is the non-psychoactive component of marijuana.

Definitely a good options for pain relief at the very least. Finally here in Canada, we are able to get our license to possess. It is however expensive.

nan17 profile image
nan17

Thanks for that update. We can only hope. Nan

Aaron98 profile image
Aaron98

I'm a bit confused. Dr. Ali Fatemi of Kennedy Krieger Institute has stated that adults with adrenomyeloneuropathy do not show any demyelination in the brain. Because of this, how would remyelinating drugs benefit us? I apologize for my lack of understanding.

monkeybus profile image
monkeybus in reply to Aaron98

Correct me if I'm wrong, but if AMN progresses into the cerebral form, isn't this where demyelination of the brain starts?

Aaron98 profile image
Aaron98 in reply to monkeybus

I believe that is what the current research indicates, monkeybus. So for those of us who never progress into adult cerebral ALD, I suppose there is no benefit to remyelinating drugs. Of course, there would be tremendous benefit for both boys and men with cerebral ALD, so I am encouraged that they are looking at possible treatments.

monkeybus profile image
monkeybus

Is this right that they are trying to patent CBD?

I don't really buy into the evil big pharma story, but this certainly makes me think twice.

You may also like...

AMN Study for Future Trial

Fish oil (DHA) + Lorenzo's oil

to LO and treatment with a cholesterol lowering drug, atorvastatin, increased DHA levels in plasma...

More controversial medication. I still don;t care if you are anti.

interested I can go into more detail. My tincture is 100% CBD and around 20% THC.